PMC:7299399 / 27713-27937 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T104","span":{"begin":103,"end":111},"obj":"Disease"}],"attributes":[{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Although it is unlikely that novel adjuvants would be used in the context of the current pandemic, the SARS-CoV-2 pandemic offers an opportunity to reflect on the potential of nanotechnology for vaccine adjuvant development."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T207","span":{"begin":35,"end":44},"obj":"Chemical"},{"id":"T208","span":{"begin":203,"end":211},"obj":"Chemical"}],"attributes":[{"id":"A207","pred":"chebi_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A208","pred":"chebi_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"Although it is unlikely that novel adjuvants would be used in the context of the current pandemic, the SARS-CoV-2 pandemic offers an opportunity to reflect on the potential of nanotechnology for vaccine adjuvant development."}

{"project":"LitCovid-sentences","denotations":[{"id":"T108","span":{"begin":0,"end":224},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although it is unlikely that novel adjuvants would be used in the context of the current pandemic, the SARS-CoV-2 pandemic offers an opportunity to reflect on the potential of nanotechnology for vaccine adjuvant development."}

{"project":"LitCovid-PubTator","denotations":[{"id":"419","span":{"begin":103,"end":113},"obj":"Species"}],"attributes":[{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Although it is unlikely that novel adjuvants would be used in the context of the current pandemic, the SARS-CoV-2 pandemic offers an opportunity to reflect on the potential of nanotechnology for vaccine adjuvant development."}